BriaCell Therapeutics Corp.
BCTXW · NASDAQ
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Market Cap | $16 | $21 | $39,050 | $44,623 |
| - Cash | $10,494 | $862 | $21,251 | $41,042 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$10,477 | -$841 | $17,799 | $3,581 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$107 | -$83 | -$20 | -$19 |
| % Margin | – | – | – | – |
| EBITDA | -$26,589 | -$4,772 | -$27,221 | -$34,047 |
| % Margin | – | – | – | – |
| Net Income | -$26,487 | -$4,716 | -$20,302 | -$11,581 |
| % Margin | – | – | – | – |
| EPS Diluted | -62.6 | -42.99 | -1.74 | -1.73 |
| % Growth | -45.6% | -2,370.7% | -0.6% | – |
| Operating Cash Flow | -$28,171 | -$24,126 | -$23,745 | -$12,484 |
| Capital Expenditures | $0 | -$457 | $0 | $0 |
| Free Cash Flow | -$28,171 | -$24,583 | -$23,745 | -$12,484 |